Similar articles for PMID: 16235571

Year	Number of Results
1991	2
1992	1
1993	2
1996	1
1998	1
2001	1
2002	5
2003	4
2004	9
2005	15
2006	14
2007	24
2008	20
2009	15
2010	2
2011	3
2012	5
2013	2
2014	2
2016	2
2018	2
2020	1
2021	1
2024	0

1

Sequence-based protein kinase inhibition: applications for drug development.

Wexler ID, Niv MY, Reuveni H. Wexler ID, et al. Biotechniques. 2005 Oct;39(4):575-6. Biotechniques. 2005. PMID: 16235571 No abstract available.

2

Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.

Collins I, Caldwell J, Fonseca T, Donald A, Bavetsias V, Hunter LJ, Garrett MD, Rowlands MG, Aherne GW, Davies TG, Berdini V, Woodhead SJ, Davis D, Seavers LC, Wyatt PG, Workman P, McDonald E. Collins I, et al. Bioorg Med Chem. 2006 Feb 15;14(4):1255-73. doi: 10.1016/j.bmc.2005.09.055. Epub 2005 Oct 24. Bioorg Med Chem. 2006. PMID: 16249095

3

Potent and selective pyrazole-based inhibitors of B-Raf kinase.

Hansen JD, Grina J, Newhouse B, Welch M, Topalov G, Littman N, Callejo M, Gloor S, Martinson M, Laird E, Brandhuber BJ, Vigers G, Morales T, Woessner R, Randolph N, Lyssikatos J, Olivero A. Hansen JD, et al. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4692-5. doi: 10.1016/j.bmcl.2008.07.002. Epub 2008 Jul 5. Bioorg Med Chem Lett. 2008. PMID: 18676143

4

Crystallography-independent determination of ligand binding modes.

Orts J, Tuma J, Reese M, Grimm SK, Monecke P, Bartoschek S, Schiffer A, Wendt KU, Griesinger C, Carlomagno T. Orts J, et al. Angew Chem Int Ed Engl. 2008;47(40):7736-40. doi: 10.1002/anie.200801792. Angew Chem Int Ed Engl. 2008. PMID: 18767090 No abstract available.

5

Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.

Prudent R, Moucadel V, Laudet B, Barette C, Lafanechère L, Hasenknopf B, Li J, Bareyt S, Lacôte E, Thorimbert S, Malacria M, Gouzerh P, Cochet C. Prudent R, et al. Chem Biol. 2008 Jul 21;15(7):683-92. doi: 10.1016/j.chembiol.2008.05.018. Chem Biol. 2008. PMID: 18635005

6

Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.

Nie Z, Perretta C, Erickson P, Margosiak S, Almassy R, Lu J, Averill A, Yager KM, Chu S. Nie Z, et al. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4191-5. doi: 10.1016/j.bmcl.2007.05.041. Epub 2007 May 18. Bioorg Med Chem Lett. 2007. PMID: 17540560

7

Identification of death-associated protein kinases inhibitors using structure-based virtual screening.

Okamoto M, Takayama K, Shimizu T, Ishida K, Takahashi O, Furuya T. Okamoto M, et al. J Med Chem. 2009 Nov 26;52(22):7323-7. doi: 10.1021/jm901191q. J Med Chem. 2009. PMID: 19877644

8

Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2).

Lovering F, Kirincich S, Wang W, Combs K, Resnick L, Sabalski JE, Butera J, Liu J, Parris K, Telliez JB. Lovering F, et al. Bioorg Med Chem. 2009 May 1;17(9):3342-51. doi: 10.1016/j.bmc.2009.03.041. Epub 2009 Mar 26. Bioorg Med Chem. 2009. PMID: 19364658

9

Characterization of compound 584, an Abl kinase inhibitor with lasting effects.

Puttini M, Redaelli S, Moretti L, Brussolo S, Gunby RH, Mologni L, Marchesi E, Cleris L, Donella-Deana A, Drueckes P, Sala E, Lucchini V, Kubbutat M, Formelli F, Zambon A, Scapozza L, Gambacorti-Passerini C. Puttini M, et al. Haematologica. 2008 May;93(5):653-61. doi: 10.3324/haematol.12212. Epub 2008 Mar 26. Haematologica. 2008. PMID: 18367480 Free article.

10

Design strategies for protein kinase inhibitors.

Parang K, Sun G. Parang K, et al. Curr Opin Drug Discov Devel. 2004 Sep;7(5):617-29. Curr Opin Drug Discov Devel. 2004. PMID: 15503864 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

122 results

Results by year